Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China flag China · Delayed Price · Currency is CNY
11.71
-0.46 (-3.78%)
Aug 24, 2026, 3:04 PM CST

SHE:300003 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
6,1636,3446,0597,91610,55310,613
Other Revenue
164.41138.9944.264.2456.9346.74
6,3286,4836,1037,98010,60910,660
Revenue Growth
3.92%6.22%-23.52%-24.79%-0.47%32.61%
Cost of Revenue
2,4942,4452,5562,9824,0214,166
Gross Profit
3,8334,0383,5474,9986,5886,494
Selling, General & Admin
1,8141,8782,2362,4402,7762,858
Research & Development
874.3792.38769.56879.42957.06907.94
Other Operating Expenses
131.7169.4363.2858.3733.9103.14
Operating Expenses
2,8672,7793,1193,4043,7933,882
Operating Income
966.711,259427.991,5942,7952,612
Interest Expense
-270.95-176.64-181-170.65-188.78-228.49
Interest & Investment Income
128.19120.96115.51115.3487.9957.59
Currency Exchange Gain (Loss)
-59.03-49.7126.91-25.3816.146.58
Other Non Operating Income (Expenses)
-20.98-31.3-34.13-4.22-25.77-79.03
EBT Excluding Unusual Items
743.941,122355.291,5092,6842,368
Impairment of Goodwill
---62.95-33.45--
Gain (Loss) on Sale of Investments
10.561.55-89.32-13.44-70.91-367.54
Gain (Loss) on Sale of Assets
5.844.8711.73-4.070.0219.9
Asset Writedown
-39.72-39.62-65.5-6.93-1.72-2.39
Other Unusual Items
151.29126.976.52103.55-127.71
Pretax Income
871.911,216225.761,5542,6122,146
Income Tax Expense
95.68197.0728.47262.15365.73365.73
Earnings From Continuing Operations
776.231,019197.291,2922,2461,780
Minority Interest in Earnings
-5.67-5749.64-34.15-42.28-61.09
Net Income
770.56962.01246.941,2582,2041,719
Net Income to Common
770.56962.01246.941,2582,2041,719
Net Income Growth
220.24%289.57%-80.37%-42.91%28.18%-4.58%
Shares Outstanding (Basic)
1,8431,8431,8481,8621,8021,792
Shares Outstanding (Diluted)
1,8431,8431,8481,8621,8171,808
Shares Change
-0.07%-0.27%-0.74%2.48%0.50%1.75%
EPS (Basic)
0.420.520.130.681.220.96
EPS (Diluted)
0.420.520.130.681.210.95
EPS Growth
220.46%290.64%-80.23%-44.29%27.54%-6.22%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
593.78873.8675.82145.691,8852,078
Free Cash Flow Per Share
0.320.470.040.081.041.15
Dividend Per Share
0.3260.3260.2770.3310.3410.275
Dividend Growth
9.32%17.51%-16.42%-2.81%24.00%20.61%
Gross Margin
60.58%62.28%58.12%62.63%62.10%60.92%
Operating Margin
15.28%19.42%7.01%19.97%26.34%24.50%
Profit Margin
12.18%14.84%4.05%15.77%20.77%16.13%
Free Cash Flow Margin
9.38%13.48%1.24%1.83%17.77%19.49%
EBITDA
1,5601,841927.052,0403,2053,004
EBITDA Margin
24.65%28.40%15.19%25.57%30.21%28.18%
D&A For EBITDA
592.95581.89499.06446.75410.11392.37
EBIT
966.711,259427.991,5942,7952,612
EBIT Margin
15.28%19.42%7.01%19.97%26.34%24.50%
Effective Tax Rate
10.97%16.21%12.61%16.86%14.00%17.04%
Revenue as Reported
6,3286,4836,1037,98010,60910,660
Advertising Expenses
-20.1928.4984.2360.0876.04